临床数据表明，对于cdk4/6i治疗失败后的晚期HR+/HER2-乳腺癌患者，羟氯喹联合大剂量cdk4/6抑制剂哌柏西利（200 mg，每天一次）的 ...

Gene expression testing helps determine chemotherapy needs for hormone receptor-positive breast cancer, optimizing treatment ...